United States · FDA National Drug Code directory
CINQAIR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59310-610_a509df2c-67b6-40c3-8b6d-f9de54b62c8a
- Product NDC
- 59310-610
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- Reslizumab
- Labeler
- Teva Respiratory, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20160418
- Source listing expiry
- 20271231
Source-listed ingredients
- RESLIZUMAB — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (59310-610-31) / 10 mL in 1 VIAL, SINGLE-USE · 59310-610-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →